Leon O. Jr Moulder, Chief Executive Officer of Zenas BioPharma, Inc. (ZBIO), purchased 60,000 shares of the company's stock on May 18, 2026. The transaction was executed at a price of $16.88 per share, totaling approximately $1.01 million.
Insider purchases are often viewed by investors as a bullish signal, indicating that company executives have strong confidence in the firm's future prospects and valuation. This recent acquisition by Mr. Moulder aligns with several other significant purchases made by the CEO in recent months.
Including this latest transaction, Mr. Moulder has acquired shares on multiple occasions since late March 2026. Prior buys include 35,